https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-04-01 / Immunol. Rev. 2008 Apr;222:256-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-04-01 / Immunol. Rev. 2008 Apr;222:256-762008-04-01 00:00:002008-04-01 00:00:00Reengineering dendritic cell-based anti-cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-03-01 / Int J Hyperthermia 2008 Mar;24(2):171-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-03-01 / Int J Hyperthermia 2008 Mar;24(2):171-812008-03-01 00:00:002008-03-01 00:00:00The importance of schedule in whole body thermochemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-05 / Br. J. Cancer 2008 Feb;98(4):784-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-05 / Br. J. Cancer 2008 Feb;98(4):784-912008-02-05 00:00:002008-02-05 00:00:00Immunisation with ’naïve‘ syngeneic dendritic cells protects mice from tumour challenge
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Zhonghua Zhong Liu Za Zhi 2008 Feb;30(2):107-11
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Zhonghua Zhong Liu Za Zhi 2008 Feb;30(2):107-112008-02-01 00:00:002008-02-01 00:00:00[Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-01 / Int. J. Oncol. 2007 Dec;31(6):1357-65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-01 / Int. J. Oncol. 2007 Dec;31(6):1357-652007-12-01 00:00:002007-12-01 00:00:00Characteristics of hybrid cells obtained by dendritic cell/tumour cell fusion in a T-47D breast cancer cell line model indicate their potential as anti-tumour vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-15 / Cancer 2007 Oct;110(8):1677-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-15 / Cancer 2007 Oct;110(8):1677-862007-10-15 00:00:002007-10-15 00:00:00Breast cancer vaccines: promise for the future or pipe dream?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-09 / Br. J. Cancer 2007 Nov;97(9):1251-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-09 / Br. J. Cancer 2007 Nov;97(9):1251-92007-10-09 00:00:002019-02-15 08:50:17Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-05 / Cancer Immunol. Immunother. 2008 May;57(5):611-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-05 / Cancer Immunol. Immunother. 2008 May;57(5):611-222007-09-05 00:00:002007-09-05 00:00:00An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Cancer Res. 2007 Aug;67(15):7477-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Cancer Res. 2007 Aug;67(15):7477-862007-08-01 00:00:002019-02-15 08:50:19A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-292007-08-01 00:00:002007-08-01 00:00:00Benefits of superficial hyperthermia treatment planning: five case studies
